CurifyLabs Strengthens Leadership Team with Key Appointments: CFO Timo Ala-Kokkila and US General Manager Shawn Brinson

CurifyLabs Strengthens Leadership Team with Key Appointments: CFO Timo Ala-Kokkila and US General Manager Shawn Brinson

At CurifyLabs, we are on a mission to transform the way medicines are made — bringing patient-centered, personalized treatments closer to those who need them. To accelerate our growth journey, we are excited to announce two strategic additions to our leadership team: Timo Ala-Kokkila as Chief Financial Officer (CFO) and Shawn Brinson as General Manager, US.

Welcoming Timo Ala-Kokkila as CFO

Timo joins CurifyLabs with extensive financial leadership experience across fast-growing companies and international markets. As CFO, he will play a central role in steering our financial strategy, scaling operations, and supporting our global expansion. His proven track record in building strong financial frameworks for startups will be invaluable as CurifyLabs grows into new markets and strengthens its position in the compounding landscape.

Welcoming Shawn Brinson as General Manager, US

Shawn brings over a decade of leadership experience from global healthcare leaders, including B. Braun Medical Inc. and Johnson & Johnson. With a strong background in commercial strategy, Shawn will lead CurifyLabs’ expansion into the United States. This marks a major milestone for us as we build our presence in one of the world’s most important healthcare markets.

Driving Rapid Growth with a World-Class Team

With these appointments, CurifyLabs continues to build a world-class leadership team to scale globally. Timo and Shawn join us at a pivotal moment, as we expand quickly and turn our vision of patient-centered solutions for personalized medicines into reality.

We are thrilled to welcome them both to CurifyLabs and look forward to shaping the future of personalized medicine together.